Omeros (OMER) Cash from Investing Activities (2010 - 2026)
Omeros recorded quarterly Cash from Investing Activities of $28.7 million in Q1 2026, down 74.24% quarter-over-quarter from $111.5 million in Q4 2025, and down 25.45% year-over-year from $38.5 million in Q1 2025.
Omeros' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at $28.7 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 25.45% year-over-year to $28.7 million; the TTM figure through Mar 2026 stood at $154.7 million (down 15.31% YoY), while the FY2025 annual figure was $164.5 million, up 100.11% from the prior year.
- Cash from Investing Activities came in at $28.7 million for Q1 2026 at Omeros, down from $111.5 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $116.2 million in Q4 2023 to a low of -$181.3 million in Q1 2023.
- A 5-year average of $10.3 million and a median of $33.0 million in 2022 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities plunged 332.87% in 2022 and soared 219.12% in 2025, its largest moves.
- Omeros' Cash from Investing Activities stood at -$108.5 million in 2022, then jumped by 207.15% to $116.2 million in 2023, then tumbled by 69.93% to $35.0 million in 2024, then jumped by 219.12% to $111.5 million in 2025, then plunged by 74.24% to $28.7 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $28.7 million, $111.5 million, and -$6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 28.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.73 Mn |
| Mar 31, 2026 | 28.73 Mn |
| Dec 31, 2025 | 111.55 Mn |
| Dec 31, 2025 | 111.55 Mn |
| Sep 30, 2025 | -6.86 Mn |
| Sep 30, 2025 | -6.86 Mn |
| Jun 30, 2025 | 21.30 Mn |
| Jun 30, 2025 | 21.30 Mn |
| Mar 31, 2025 | 38.54 Mn |
| Mar 31, 2025 | 38.54 Mn |
| Dec 31, 2024 | 34.95 Mn |
| Dec 31, 2024 | 34.95 Mn |
| Sep 30, 2024 | 36.04 Mn |
| Sep 30, 2024 | 36.04 Mn |
| Jun 30, 2024 | 73.15 Mn |
| Jun 30, 2024 | 73.15 Mn |
| Mar 31, 2024 | -61.93 Mn |
| Mar 31, 2024 | -61.93 Mn |
| Dec 31, 2023 | 116.24 Mn |
| Dec 31, 2023 | 116.24 Mn |
| Sep 30, 2023 | 57.17 Mn |
| Sep 30, 2023 | 57.17 Mn |
| Jun 30, 2023 | 35.38 Mn |
| Jun 30, 2023 | 35.38 Mn |
| Mar 31, 2023 | -181.33 Mn |
| Mar 31, 2023 | -181.33 Mn |
| Dec 31, 2022 | -108.49 Mn |
| Dec 31, 2022 | -108.49 Mn |
| Sep 30, 2022 | 33.00 Mn |
| Sep 30, 2022 | 33.00 Mn |
| Jun 30, 2022 | 24.74 Mn |
| Jun 30, 2022 | 24.74 Mn |
| Mar 31, 2022 | -76.81 Mn |
| Mar 31, 2022 | -76.81 Mn |
| Dec 31, 2021 | 112.42 Mn |
| Dec 31, 2021 | 112.42 Mn |
| Sep 30, 2021 | 17.90 Mn |
| Sep 30, 2021 | 17.90 Mn |
| Jun 30, 2021 | 30.41 Mn |
| Jun 30, 2021 | 30.41 Mn |
| Mar 31, 2021 | 32.99 Mn |
| Mar 31, 2021 | 32.99 Mn |
| Dec 31, 2020 | 8.00 Mn |
| Dec 31, 2020 | 8.00 Mn |
| Sep 30, 2020 | -118.40 Mn |
| Sep 30, 2020 | -118.40 Mn |
| Jun 30, 2020 | 32.59 Mn |
| Jun 30, 2020 | 32.59 Mn |
| Mar 31, 2020 | 10.78 Mn |
| Mar 31, 2020 | 10.78 Mn |
| Dec 31, 2019 | -39.24 Mn |
| Dec 31, 2019 | -39.24 Mn |
| Sep 30, 2019 | 9.34 Mn |
| Sep 30, 2019 | 9.34 Mn |
| Jun 30, 2019 | 15.21 Mn |
| Jun 30, 2019 | 15.21 Mn |
| Mar 31, 2019 | 11.29 Mn |
| Mar 31, 2019 | 11.29 Mn |
| Dec 31, 2018 | -2.36 Mn |
| Dec 31, 2018 | -2.36 Mn |
| Sep 30, 2018 | 33.06 Mn |
| Sep 30, 2018 | 33.06 Mn |
| Jun 30, 2018 | -14.10 Mn |
| Jun 30, 2018 | -14.10 Mn |
| Mar 31, 2018 | 8.55 Mn |
| Mar 31, 2018 | 8.55 Mn |
| Dec 31, 2017 | 5.43 Mn |
| Dec 31, 2017 | 5.43 Mn |
| Sep 30, 2017 | -59.54 Mn |
| Sep 30, 2017 | -59.54 Mn |
| Jun 30, 2017 | 5.85 Mn |
| Jun 30, 2017 | 5.85 Mn |
| Mar 31, 2017 | 10.66 Mn |
| Mar 31, 2017 | 10.66 Mn |
| Dec 31, 2016 | -6.01 Mn |
| Dec 31, 2016 | -6.01 Mn |
| Sep 30, 2016 | -20.54 Mn |
| Sep 30, 2016 | -20.54 Mn |
| Jun 30, 2016 | -4.42 Mn |
| Jun 30, 2016 | -4.42 Mn |
| Mar 31, 2016 | 14.63 Mn |
| Mar 31, 2016 | 14.63 Mn |
| Dec 31, 2015 | 7.45 Mn |
| Dec 31, 2015 | 7.45 Mn |
| Sep 30, 2015 | 14.41 Mn |
| Sep 30, 2015 | 14.41 Mn |
| Jun 30, 2015 | 19.62 Mn |
| Jun 30, 2015 | 19.62 Mn |
| Mar 31, 2015 | -62.09 Mn |
| Mar 31, 2015 | -62.09 Mn |
| Dec 31, 2014 | 14.48 Mn |
| Dec 31, 2014 | 14.48 Mn |
| Sep 30, 2014 | 14.89 Mn |
| Sep 30, 2014 | 14.89 Mn |
| Jun 30, 2014 | 15.70 Mn |
| Jun 30, 2014 | 15.70 Mn |
| Mar 31, 2014 | -38.91 Mn |
| Mar 31, 2014 | -38.91 Mn |
| Dec 31, 2013 | -4.94 Mn |
| Dec 31, 2013 | -4.94 Mn |
| Sep 30, 2013 | 10.45 Mn |
| Sep 30, 2013 | 10.45 Mn |
| Jun 30, 2013 | -6.31 Mn |
| Jun 30, 2013 | -6.31 Mn |
| Mar 31, 2013 | 8.71 Mn |
| Mar 31, 2013 | 8.71 Mn |
| Dec 31, 2012 | 8.33 Mn |
| Dec 31, 2012 | 8.33 Mn |
| Sep 30, 2012 | -29.66 Mn |
| Sep 30, 2012 | -29.66 Mn |
| Jun 30, 2012 | 742,000.00 |
| Jun 30, 2012 | 742,000.00 |
| Mar 31, 2012 | 19.68 Mn |
| Mar 31, 2012 | 19.68 Mn |
| Dec 31, 2011 | 7.36 Mn |
| Dec 31, 2011 | 7.36 Mn |
| Sep 30, 2011 | 4.74 Mn |
| Sep 30, 2011 | 4.74 Mn |
| Jun 30, 2011 | 6.49 Mn |
| Jun 30, 2011 | 6.49 Mn |
| Mar 31, 2011 | -1.68 Mn |
| Mar 31, 2011 | -1.68 Mn |
| Dec 31, 2010 | -7.05 Mn |
| Dec 31, 2010 | -7.05 Mn |
| Sep 30, 2010 | 7.14 Mn |
| Sep 30, 2010 | 7.14 Mn |